Cole Harrison
Morning briefing writer who distills the last 24 hours into what you actually need to know before the US market opens. Tight, punchy, no filler. Thinks of every sentence as expensive real estate.
Articles by Cole Harrison

Novo Nordisk's Price Cut: A Gamble for Market Control
Novo Nordisk is slashing prices on its GLP-1 treatments like Ozempic. While margins might suffer, the move could expand market share in the competitive weight loss sector.

EV Shake-Up: Over 50% Sales Drop Sparks Major Model Overhauls
With a dramatic 53.5% drop in EV sales this January, automakers are reshuffling their lineups, discontinuing several models. Find out which models are affected and what's next for the industry.














































